Pharmacovigilance and Drug Safety

This is both challenging and exciting to write an editorial for the journal Pharmacovigilance and Drug Safety. The number of medicines in the market has increased dramatically over the last few years, bringing some real innovations, but also considerable challenges in controlling the quality and rational use of medicines. Safety of medicines is an important issue. Due to intense competition among pharmaceutical manufacturers, products may be registered and marketed in many countries simultaneously. As a result adverse effect may go unnoticed and so are not monitored systematically. Pharmacovigilance is a structured process for the monitoring and detection of adverse drug reactions in the given context.

 

This is both challenging and exciting to write an editorial for the journal Pharmacovigilance and Drug Safety. The number of medicines in the market has increased dramatically over the last few years, bringing some real innovations, but also considerable challenges in controlling the quality and rational use of medicines. Safety of medicines is an important issue. Due to intense competition among pharmaceutical manufacturers, products may be registered and marketed in many countries simultaneously. As a result adverse effect may go unnoticed and so are not monitored systematically. Pharmacovigilance is a structured process for the monitoring and detection of adverse drug reactions in the given context.

 

The motive of drug companies in production of new pharmaceutical product is the maximization of profits. Production and distribution of counterfeit medicines is acknowledged to be another problem of great magnitude in many developing countries.

 

In the era of globalization and information explosion, it has become critical to safeguard the patients from the side effects of drug. Due to ignorance of patients, it has become mandatory to teach and correct every drug you prescribe to a patient. Concern about adverse effects and drug interaction has increased worldwide. At this juncture the journal titled ‘Pharmacovigilance and Drug Safety’ sets a new paradigm for pharmacy practice. The journal focuses on Pharmacovigilance and and has role in protecting the patients from undesirable drug effects and drug related problems by publishing research articles of high standard.

 

This international journal is open access, peer reviewed and first issue has been released successfully. Mission of the journal is to become most popular open access journal in the field of science by publishing high quality articles. The journal also aims to report innovative, evidence based research articles related to pharmacology, drug delivery etc ,which will further contribute to the advancement of Pharmacovigilance.

 

We look forward to publish articles of good scientific merit and invite researchers across the globe to be a part of our mission by contributing valuable articles to the journal.

 

View Full Article: HERE

Go through the  Journal: http://www.enlivenarchive.org/pharmacovigilance-and-drug-safety-open-access

Contact Us: pharmacovigilance-drugsafety@enlivenarchive.org

 

Role of Pharmacovigilance in Drug Development

Pharmacovigilance (PV) is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug related problem. PV collects, records, codes ADEs/ADRs analyses and assesses the reports, promotes the safe use of drugs, creates appropriate structures and means of communication needed to perform its tasks. The aims of PV are to improve patient care and safety, improve public health and safety, contribute to the assessment of benefit, harm, effectiveness and risk of medicines, promote education and clinical training, promote effective communication to public and promote rational and safe use of medicines.

 

The process of drug discovery and development is a long-term, competitive, expensive and complicated process. Bringing the drugs from the bench to the market, that is, from screening and identification of the drug as a compound to its introduction to the market, takes several years of efforts [1].The process of discovering and developing a new drug involves an intricate interaction between investors, industry, academia, patent laws, regulatory authorities, marketing and the necessity to balance confidentiality with communication [2]. The complete process of presenting a drug to the patients involves four stages- 1. Drug discovery, 2. Drug development, 3. Regulatory review and approval, and 4. Marketing [3].

 

View Full Article: HERE

Go through the Journal: http://www.enlivenarchive.org/pharmacovigilance-and-drug-safety-open-access

Contact Us: pharmacovigilance-drugsafety@enlivenarchive.org

 

TNF? and IL-1? have Dose Dependent Effects on Differentiation of CD4+CD127-CD25highFoxP3high T cells

Regulatory T cells (TRegs) are critical for the maintenance of balanced human immune responses. The innate immune system plays a significant role in the pathogenesis of autoimmune diseases. However, its role in the differentiation and function of human CD4+ induced TRegs (iTRegs) is currently unclear. In this study we investigated the effect of the pro-inflammatory cytokines tumor necrosis factor alpha (TNFα) and IL-1β upon the differentiation and function of human CD4+FoxP3+ iTRegs.

Naïve human CD4+CD25- T cells, isolated from both cord blood (CB) and adult peripheral blood (PB) were cultured under various stimulatory conditions with/without TNFα and IL-1β. The CD4+FoxP3+ iTRegs were characterized as CD4+CD127-CD25highFoxP3high iTRegs and their suppressive function evaluated.

TNFα and IL-1β significantly affected the differentiation of human CD4+FoxP3+ iTRegs in a dose and time dependent manner. Low dose and short term conditions promoted their differentiation while high dose and long term conditions were inhibitory. In addition, the suppressive function of the CD4+FoxP3+ iTRegs was inhibited by TNFα and IL-1β. This inhibitory effect of TNFα and IL-1β was associated with a significant reduction of the transforming growth factor β receptor type II (TβRII) expression and IL-2 secretion. However, their IL-10 secretion was not affected and no IL-35 secretion was observed in any of the culture conditions tested.

We conclude that the in vitro induction of human CD4+FoxP3+ iTRegs is mediated through TβRII and IL-2 dependent mechanism. The regulatory effect of TNFα and IL-1β on CD4+FoxP3+ iTReg differentiation is dynamic and may to some extent reflect the magnitude and persistence of the initial pro-inflammatory response.

 

View Full Article: HERE

Go through the Journal: http://www.enlivenarchive.org/immunology-and-immunotechniques

Contact Us: immunology-immunotechniques@enlivenarchive.org

Augmentation of Lipopolysaccharide (lps) Receptor Expression by Interferon y Correlates with Susceptibility to lps-Induced Apoptosis in Human Monoblastic Cell Line u937

Apoptosis, accompanied with cytoplasmic shrinkage, nuclear condensation and caspase activation induced by LPS, is thought to proceed via activation of LPS receptor, which is comprised of the toll-like receptor (TLR) 4 and MD-2. We report that LPS induced apoptosis in the human monoblastic cell line U937 that was pretreated with interferon γ(U937IFN), but not in cells that were untreated or treated with retinoic acid (U937RA). To reveal the reason why interferon LipoPolySaccharide (LPS); Apoptosis; LPS receptor; Differentiation; Monocyte LipoPolySaccharide (LPS); Apoptosis; LPS receptor; Differentiation; Monocyte γ(IFN) confers apoptotic susceptibility to U937 cells, we focused on the LPS receptor. IFN stimulated the expression of cell surface TLR4 and the transcription level of MD-2 mRNA. By transfecting a designed antisense oligonucleotide (ASO) into U937IFN cells before exposing to LPS, the expression level of TLR4 was lowered to levels comparable to those in U937 cells; ASO transfected-cells showed no cleavage of poly (ADP-ribose) polymerase (PARP) and exhibited no morphological changes. Addition of an anti-TLR4 monoclonal antibody to the cultures of U937IFN cells along with LPS resulted in reduction of the Ac-DEVD-MCA hydrolysis and inhibition of the PARP cleavage. Neither a loss of function form of FADD, an adaptor molecule for death receptor signaling, nor a neutralization antibody against TNF-α or Fas prevented LPS-triggered apoptosis, indicating that the death ligand and death receptor were not activated. These results suggest that IFN induces expression of the LPS receptor, resulting in increased susceptibility to LPS-induced apoptosis.

 

View Full Article: HERE

Go through the Journal: http://www.enlivenarchive.org/immunology-and-immunotechniques

Contact Us: immunology-immunotechniques@enlivenarchive.org

Development and Validation of Spectrophotometric Method for Determination of Thiamine (VB1) in Pharmaceutical Formulations using 1,2-Naphthoquine-4-Sulphonate (NQS)

Simple and sensitive spectrophotometric method for the determination of thiamine (VB1) in pharmaceutical formulations has been reported. The proposed method is based on the reaction between the (VB1) and sodium 1,2-naphthoquine-4-sulphonate (NQS) at alkaline medium (pH 11) to form deep brown product. Beer’s law is obeyed in the range 10-40 µg/ml of thiamine at maximum wavelength of 487 nm. Under optimized reaction conditions, linear regression equation of the calibration curve is: A= 0.022x + 0.171 (µg/ml) with a linear correlation coefficient of 0.997. The limit of detection (LOD) and limit of quantification (LOQ) were found to be 1.71 µg/mL and 5.18 µg/ml respectively. The method has been successfully applied to the determination of thiamine (VB1) in pharmaceutical formulations, and can be used as a replacement of the existing sophisticated method used in quality control laboratories.

 

View Full Article: HERE

Go through the Journal: http://www.enlivenarchive.org/bioanalytical-techniques-open-access

Contact Us: bioanalyticaltechniques@enlivenarchive.org

Quantification of the Molecular Species of Tetraacylglycerols in Lesquerella (Physaria fendleri) Oil by HPLC with ELSD and MS

Thirteen molecular species of tetraacylglycerols in the seed oil of Physaria fendleri were recently identified. We report here the quantification of the molecular species of these tetraacylglycerols using HPLC with evaporative light scattering detector and the MS of the HPLC fractions. The ion signal intensities of MS1 from the molecular species of acylglycerols with different m/z in HPLC fractions were used to estimate the ratios of the molecular species. The ratios of the molecular species of acylglycerols with the same mass were estimated by the total ion signal intensities of the fragment ions of MS2, [M + Li ? FA]+ and [M + Li ? FA-FA]+. The content of tetraacylglycerols was about 1%. The highest contents of the molecular species of tetraacylglycerols were from those containing one normal FA (non-hydroxylated fatty acid) and they were LsLsLsO (0.25%), LsLsLsL (0.24%), LsLsLsLn (0.21%) and LsLs-OH20:2-O (0.19%). The contents of the tetraacylglycerols containing two normal FA were lower than those containing one normal FA. Among them the highest were LsLsOL (0.10%), LsLsOO (0.06%) and LsLsOLn (0.06%).

 

View Full Article: HERE

Go through the Journal: http://www.enlivenarchive.org/bioanalytical-techniques-open-access

Contact Us: bioanalyticaltechniques@enlivenarchive.org

 

Highly Sensitive Analysis of Endocrine Disrupting Chemicals in Pharmaceutical Wastes using Molecularly Imprinted Polymer Extraction hyphenated with Liquid Chromatography-Mass Spectrometry

Environmental loading of endocrine disrupting chemicals (EDCs) that originate from pharmaceutical wastes are known to cause adverse impacts on aquatic life and public health. In this article, a new sensitive method has been proposed for quantification of EDCs in complicated pharmaceutical wastes using a molecularly imprinted polymer (MIP) extraction followed by liquid chromatograph-mass spectrometer (LC-MS) analysis. The calibration curves of EDCs showed linearity in the concentration range of 1-100 µg L-1 (r>0.996) with a 10 mL loading of pharmaceutical waste samples. The EDCs recoveries obtained by the MIP for pharmaceutical effluents, air particulates and treated sludge were 91%, 89% and 84%, respectively; and the recovery values were better than the conventional SPE materials such as powdered activated carbon and resin. The quantification of 17β-estradiol, a model EDC molecule, using LC-MS showed an excellent lower limits of detection in the pharmaceutical effluents, air particulates and solid waste in the order of 0.19 µg L-1, 0.13 µg g-1, 0.12 µg g-1, respectively.

 

View Full Article: HERE

 

Go through the Journal: http://www.enlivenarchive.org/bioanalytical-techniques-open-access

 

Contact US: bioanalyticaltechniques@enlivenarchive.org

 

Quantitation of Amino Acids in Human Hair by Trimethylsilyl Derivatization Gas Chromatography/Mass Spectrometry

The distribution of amino acids in hair can divulge information regarding the health (e.g., diabetes) and provide a means for detecting the history of the disease by segmentation of the hair as well as attributes of an individual (e.g., sex and age). Therefore, an nonenzymatic method of hair digestion and profiling is required. In addition to optimizing and validating a method for measuring the distribution of amino acids in human hair, a robust and comprehensive approach to objectively compare the most effective means of extracting and manipulating chromatographic data to obtain the best limits of detection, linearity, and sensitivity are provided.

 

View Full Article: HERE 

Go through the Journal: http://www.enlivenarchive.org/bioanalytical-techniques-open-access

Contact Us: bioanalyticaltechniques@enlivenarchive.org

Isolation of Incensole and Molecular Docking on Human Aldose Reductase

The objective of this work is the docking of incensole isolated from Boswellia carterii. The molecular target is human aldose reductase (ALR2) whose crystallographic structure was obtained from protein data bank with access code 2NVC. Docking analysis was performed using the MOE, 10.2009. The docking studies of the ligand incensole with ALR2 showed that this is a good inhibitor molecule. Therefore, incensole can be considered for developing into a potent ALR2- inhibitor drug.

 

View Full Article: HERE

Go through the Journal: http://www.enlivenarchive.org/bioanalytical-techniques-open-access

Contact Us: bioanalyticaltechniques@enlivenarchive.org

SNPs of ASPM Suggested Population Differentiation and Genographic Patterns among Diverse Population

Signatures of positive selection in ASPM across human lineage suggest a rich pool of genetic variation. SNPs are one of the most common types of genetic variations and essential for deeper understanding of population differentiation.

 

View Full Article: HERE

Go through the Journal: http://www.enlivenarchive.org/genetic-molecular-and-cellular-biology

Contact Us: genetics@enlivenarchive.org